FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Esophagus TNM finding (finding) American Joint Committee on Cancer allowable value
Essential thrombocythaemia (disorder) thrombocythémie essentielle
Estimated creatine clearance Estimated creatinine clearance
Estimated creatine clearance Estimated creatinine clearance
Estimated creatine clearance (procedure) Estimated creatinine clearance
Estimated date of delivery from last normal period Estimated date of delivery from last period
Estimated total energy intake (observable entity) Estimated quantity of intake of energy in 24 hours (observable entity)
Estradiol Estradiol
Estradiol + norethindrone acetate 0.62mg/2.7mg (product) Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.025mg/day patch (product) Estradiol 1.04 microgram/hour prolonged-release transdermal patch
Estradiol 0.025mg/unt (product) Estradiol 1.04 microgram/hour prolonged-release transdermal patch
Estradiol 0.0375mg/day (product) Estradiol 1.56 microgram/hour prolonged-release transdermal patch
Estradiol 0.0375mg/day patch (product) Estradiol 1.56 microgram/hour prolonged-release transdermal patch
Estradiol 0.05 mg/day (product) Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.05mg/24 hr (product) Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.05mg/day (product) Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.05mg/day patch (product) Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch (product) Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch (product) Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.06mg/day transdermal patch (product) Estradiol 2.5 microgram/hour prolonged-release transdermal patch
Estradiol 0.075mg/day (product) Estradiol 3.13 microgram/hour prolonged-release transdermal patch
Estradiol 0.075mg/day patch (product) Estradiol 3.13 microgram/hour prolonged-release transdermal patch
Estradiol 0.1mg/day (product) Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 0.1mg/day patch (product) Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 14mcg/day transdermal patch (product) Estradiol 583 nanogram/hour prolonged-release transdermal patch
Estradiol 25mcg pessary (product) Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug)
Estradiol 3.9mg/patch Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Estradiol 5.75mg (product) Estradiol 3.13 microgram/hour prolonged-release transdermal patch
Estradiol 5.85mg (product) Estradiol 3.13 microgram/hour prolonged-release transdermal patch
Estradiol implant allergy Allergy to estradiol (finding)
Ethanoic acid acide acétique (substance)
Ethanolamine oleate 5% injection solution ampule (product) Product containing only ethanolamine in parenteral dose form (medicinal product form)
Ether hydrolase Ether hydrolase
Ether, anesthetic adverse reaction Adverse reaction to inhaled anesthetic with ether structure
Ether, anesthetic allergy Allergy to substance with ether structure
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch (product) Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Ethnic form of nose - finding (finding) Finding of appearance of nose
Ethnic group not given - patient refused Refusal by patient to provide information about ethnic group
Ethnic group not given - patient refused Refusal by patient to provide information about ethnic group
Ethnic group not given - patient refused (finding) Refusal by patient to provide information about ethnic group
Ethylene oxide specific extract (product) Product containing ethylene oxide (medicinal product)
Ethynodiol diacetate [progestogen oral contraceptive] (product) Product containing etynodiol (medicinal product)
Ethynodiol diacetate allergy Allergy to progestational hormone
Ethynodiol diacetate preparation (product) Product containing etynodiol (medicinal product)
Etidocaine hydrochloride 1% injection (product) Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Etidocaine hydrochloride 1% injection solution ampule Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Etidocaine hydrochloride+epinephrine 1%/1:200000 injection (product) Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Etidocaine hydrochloride+epinephrine 1.5%/1:200000 injection (product) Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug)
Etidocaine hydrochloride+epinephrine 1.5%/1:200000 injection solution 20mL vial (product) Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug)
Etidocaine hydrochloride+epinephrine 1.5%/1:200000 injection solution 2mL vial (product) Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug)
Etidronate (product) Product containing etidronic acid (medicinal product)
Etodolac 400mg m/r tablet (product) Product containing only etodolac in oral dose form (medicinal product form)
Etodolac 400mg prolonged-release oral tablet (product) Product containing only etodolac in oral dose form (medicinal product form)
Etodolac 500mg m/r tablet (product) Product containing only etodolac in oral dose form (medicinal product form)
Etodolac 500mg prolonged-release oral tablet (product) Product containing only etodolac in oral dose form (medicinal product form)
Etonogestrel 68mg subdermal implant (product) Product containing precisely etonogestrel 68 milligram/1 each prolonged-release subcutaneous implant (clinical drug)
Etonogestrel-releasing implant (product) Etonogestrel-containing product in parenteral dose form
Etoposide 100mg/5mL conventional release solution for injection (product) Etoposide only product in parenteral dose form
Etoposide 100mg/5mL injection (product) Etoposide only product in parenteral dose form
Etoposide 100mg/5mL powder for injection 5mL vial (product) Etoposide only product in parenteral dose form
Etoposide 100mg/vial injection (product) etoposide 100mg injection (pdr for recon) (médicament clinique)
Eubacterium aerofaciens Collinsella aerofaciens (organism)
Eubacterium alactolyticum (organism) Pseudoramibacter alactolyticus
Eubacterium desmolans Agathobaculum desmolans (organism)
Eubacterium exiguum Slackia exigua (organism)
Eubacterium formicigenerans Dorea formicigenerans
Eubacterium fossor Atopobium fossor (organism)
Eubacterium lentum Eggerthella lenta (organism)
Eubacterium nitrogenes Clostridium nitritogenes
Eubacterium plautii Flavonifractor plautii (organism)
Eubacterium suis Actinobaculum suis
Eubacterium tardum Eubacterium minutum
Eubacterium timidum Mogibacterium timidum
Eunuchoidism hypogonadisme chez l'homme
Euparyphium ilocanum Echinostoma ilocanum (organism)
European eel - dietary Eel (substance)
Eurypelma hentzii Aphonopelma hentzi (organism)
Evans and Lloyd-Thomas syndrome Normal variation in position
Everolimus 100 microgram/cc drug eluting stent (product) Everolimus 100 microgram/cm2 drug eluting stent
Example problem list concepts reference set (foundation metadata concept) Simple type reference set (foundation metadata concept)
Excessive hemorrhage due to and following illegally induced termination of pregnancy Excessive hemorrhage due to and following induced termination of pregnancy (disorder)
Excessive hemorrhage due to and following legally induced termination of pregnancy (disorder) Excessive hemorrhage due to and following induced termination of pregnancy (disorder)
Excessive overbite (disorder) Deep overbite
Excessive spacing of fully erupted teeth (disorder) Excessive spacing of fully erupted teeth
Excision of breast tissue Excision of breast
Excision of first rib for unlisted cause (procedure) Excision of first rib
Excision of malignant lesion of cervical esophagus with laryngectomy and radical neck dissection Excision of neck
Excision of meniscus of kne (procedure) Chondrectomy of semilunar cartilage of knee
Excision of retroperitoneal endometriomas, simple Excision of endometriotic cyst of retroperitoneum (procedure)
Excision of tissue of inguinal region Inguinal region excision
Excision of unlisted pressure ulcer with local skin flap closure and with ostectomy (procedure) Excision of pressure ulcer (procedure)
Excision of unlisted pressure ulcer with muscle or myocutaneous flap closure Excision of pressure ulcer (procedure)
Excision of vagina Vaginectomy
Execution (event) Non-judicial execution (event)
Exercise stress echocardiography Exercise stress echocardiography (procedure)
Exercise toler test equivocal Exercise tolerance test equivocal (finding)
Exocrine pancreas TNM finding (finding) American Joint Committee on Cancer allowable value
Exogenous substance receptor (substance) Receptor
Exon Finding related to molecular sequence data
Exophthalmos producing substance Thyroid ophthalmic antibody
Exoribonuclease Exoribonuclease

Start Previous Page 35 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start